<font color="blue">Intermediate_1</font> <font color="blue">-_1</font> <font color="blue">term_1</font> <font color="blue">mortality_1</font> and cardiac transplantation in infants with single - ventricle lesions : risk factors and their interaction with shunt type . 
<br>
<br> OBJECTIVE The study objective was to identify factors associated with <font color="blue">death_1</font> and cardiac transplantation in infants undergoing the Norwood procedure and to determine differences in associations that might favor the modified Blalock - Taussig shunt or a right ventricle - to - pulmonary artery shunt . 
<br> METHODS We used competing risks methodology to analyze death without transplantation , cardiac transplantation , and survival without transplantation . Parametric time - to - event modeling and bootstrapping were used to identify independent predictors . 
<br> RESULTS Data from 549 subjects ( follow - up , 2.7 Â± 0.9 years ) were analyzed . <font color="blue">Mortality_3</font> <font color="blue">risk_3</font> was characterized by early and constant phases ; <font color="blue">transplant_1</font> <font color="blue">was_1</font> <font color="blue">characterized_1</font> <font color="blue">by_1</font> <font color="blue">only_1</font> <font color="blue">a_1</font> <font color="blue">constant_1</font> <font color="blue">phase_1</font> <font color="blue">._1</font> Early phase factors associated with <font color="blue">death_2</font> included <font color="blue">lower_1</font> <font color="blue">socioeconomic_1</font> <font color="blue">status_1</font> <font color="blue">(_1</font> <font color="blue">P_1</font> <font color="blue">=_1</font> <font color="blue">.01_1</font> <font color="blue">)_1</font> <font color="blue">,_1</font> <font color="blue">obstructed_1</font> <font color="blue">pulmonary_1</font> <font color="blue">venous_1</font> <font color="blue">return_1</font> <font color="blue">(_1</font> <font color="blue">P_1</font> <font color="blue"><_1</font> <font color="blue">.001_1</font> <font color="blue">)_1</font> <font color="blue">,_1</font> <font color="blue">smaller_1</font> <font color="blue">ascending_1</font> <font color="blue">aorta_1</font> <font color="blue">(_1</font> <font color="blue">P_1</font> <font color="blue">=_1</font> <font color="blue">.02_1</font> <font color="blue">)_1</font> <font color="blue">,_1</font> <font color="blue">and_1</font> <font color="blue">anatomic_1</font> <font color="blue">subtype_1</font> <font color="blue">._1</font> Constant phase factors associated with <font color="blue">death_3</font> <font color="blue">included_1</font> <font color="blue">genetic_1</font> <font color="blue">syndrome_1</font> <font color="blue">(_1</font> <font color="blue">P_1</font> <font color="blue"><_1</font> <font color="blue">.001_1</font> <font color="blue">)_1</font> <font color="blue">and_1</font> <font color="blue">lower_1</font> <font color="blue">gestational_1</font> <font color="blue">age_1</font> ( P < .001 ) . The <font color="blue">right_1</font> <font color="blue">ventricle_1</font> <font color="blue">-_1</font> <font color="blue">to_1</font> <font color="blue">-_1</font> <font color="blue">pulmonary_1</font> <font color="blue">artery_1</font> <font color="blue">shunt_1</font> <font color="blue">demonstrated_1</font> <font color="blue">better_2</font> <font color="blue">survival_5</font> in the 51% of subjects who were full term with aortic atresia ( P < .001 ) . The modified Blalock - Taussig shunt was better among the 4% of subjects who were preterm with a patent aortic valve ( P = .003 ) . <font color="blue">Lower_1</font> <font color="blue">pre_1</font> <font color="blue">-_1</font> <font color="blue">Norwood_1</font> <font color="blue">right_1</font> <font color="blue">ventricular_1</font> <font color="blue">fractional_1</font> <font color="blue">area_1</font> <font color="blue">change_1</font> <font color="blue">,_1</font> <font color="blue">pre_1</font> <font color="blue">-_1</font> <font color="blue">Norwood_1</font> <font color="blue">surgery_1</font> <font color="blue">,_1</font> <font color="blue">and_1</font> <font color="blue">anatomy_1</font> <font color="blue">other_1</font> <font color="blue">than_1</font> <font color="blue">hypoplastic_1</font> <font color="blue">left_1</font> <font color="blue">heart_1</font> <font color="blue">syndrome_1</font> were independently associated with transplantation ( all P < .03 ) , but shunt type was not ( P = .43 ) . 
<br> CONCLUSIONS Independent risk factors for intermediate - term mortality include <font color="blue">lower_1</font> <font color="blue">socioeconomic_1</font> <font color="blue">status_1</font> <font color="blue">,_1</font> <font color="blue">anatomy_1</font> <font color="blue">,_1</font> <font color="blue">genetic_1</font> <font color="blue">syndrome_1</font> <font color="blue">,_1</font> <font color="blue">and_1</font> <font color="blue">lower_1</font> <font color="blue">gestational_1</font> <font color="blue">age_1</font> <font color="blue">._1</font> Term infants with aortic atresia <font color="blue">benefited_1</font> <font color="blue">from_1</font> <font color="blue">a_1</font> <font color="blue">right_1</font> <font color="blue">ventricle_1</font> <font color="blue">-_1</font> <font color="blue">to_1</font> <font color="blue">-_1</font> <font color="blue">pulmonary_1</font> <font color="blue">artery_1</font> <font color="blue">shunt_1</font> <font color="blue">,_1</font> and preterm infants with a patent aortic valve benefited from a modified Blalock - Taussig shunt . Right ventricular function and anatomy , but not shunt type , were associated with transplantation .